Animal cells cultured after tumor virus infection usually reveal alterations in cell surface, in growth behavior, and in the acquisition of transformed morphology in vitro and tumorigenesis in vivo (1) . However, none of them have been proven a causal relationship. For instance, enhanced agglutinabilities by lectins, disappearance of fibronectin proteins, increased proteolysis have been catalogued on changes at the cell surface of the transformed cells (1) , and not all of them have been associated with specific heritable changes in the cell genome after viral transformation.
Cells transformed by tumor viruses often result in stable alterations in cellular growth properties in vitro; in particular, the loss of contact inhibition, less dependency on serum concentration, and anchorage independency. Again, not all of the altered cellular growth properties commonly associated with transformed state would be required for neoplastic growth in vivo. Although several reports demonstrated that the tumorigenicity of virus-transformed cells is correlated specifically with anchorageindependent growth in vitro (2, 3) , several reports argue against this observation of correlation (4, 5) . Also, morphological transformation induced in vitro by the tumor virus does not guarantee tumorigenesis in vivo, or is only coincidentally related to the neoplastic state (4) .
In previous studies with Kirsten sarcoma virus-transformed mouse cells, we found that the tumorigenicity in the syngeneic mouse does not necessarily correlate with the transformed morphology of cells, nor with their state of virus production, and concluded that the presence of the sarcoma genome in cells is an essential, but not sufficient, condition of tumorigenesis (6) .
Although this inbred mouse system provided much useful information on understanding the gene expression and tumorigenesis of tumor viruses (7-9), it has two major disadvantages for analyses of the mechanism of viral oncogenesis. First, all mouse cells in culture, regardless of whether transformed or nontransformed, became heteroploid in karyotype; this seriously hinders genetic analysis of the mechanism of tumorigenesis caused by tumor viruses. Second, the use of syngeneic systems cannot obviate immune responses to viral, as well as new cellular antigens, which may be ). In initial studies we found that clonal isolates of the transformed cell line maintained the diploidal state (2n --7 in males and 2n = 6 in females); therefore, we isolated a series of cell clones from both male and female muntjac cells transformed by 43-2XV, each of which remained diploid (Hatanaka et al. Manuscript in preparation.). These transformed clonal isolates were then tested for tumorigenicity in athymic nude mice that are not able to develop the thymus as a result of a recessive autosomal mutation and, therefore, are functionally devoid of thymus-derived cell (T ceU)-dependent immunity (11, 12) . Athymic nude mice are, therefore, unable to reject transplanted tumor cells of allogeneic or xenogeneic origin (13, 14) and thus provide a convenient, immunologically neutral test system for cellular tumorigenicity (15) .
This communication presents the variable inherent expressions of tumorigenicity by the clonal isolates of Indian muntjac diploid cells that were transformed by the variable integrations of sarcoma gene of a mouse retrovirus, 43-2XV. It is possible that some transformed cells were more vulnerable than other cells to the action of humoral antibodies and the endogenous mouse component, because it is known that nude mice form humoral antibodies to heterologous skin grafts, and it has been shown that these humoral antibodies can induce necrosis in skin allografts when the mice are injected with rabbit complement (16) . We tested the effects of the sera of rabbit anti-mouse thymocyte (ATS) 1 and rabbit anti-mouse lymphocyte (ALS) l Abbreviations used in this paper: ALS, rabbit anti-mouse lymphoeytes; ATS, rabbit anti-mouse thymocytes; HA, hemagglutination. Actually, all the clonal isolates, including transformed but nontumorigenic clones, demonstrated the presence of the sarcoma gene (Hatanaka et al. Manuscript in preparation.). The results suggest that the presence of the sarcoma gene may correlate with the expression of the transformed morphology in cell culture; however, this is not necessarily accompanied by tumorigenic potential when assayed in nude mice (Table I ). This data demonstrate that a complexity exists in tumorigenicity caused by the sarcoma gene. The status of the transformed cells shedding the viruses or not producing the viruses (nonproducer) appears irrelevant for tumorigenicity in nude mice, as shown in Table I . This conforms with the previous conclusion obtained from the mouse cell transformed by the same sarcoma gene (6, 7) .
Materials and Methods
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Also, the colony formation in agarose does not correlate with the tumorigenicity tested in nude mice (Table I) . Despite typical morphological transformation and colony formation in agarose with hypoxanthine aminopterin thymidine + Rajithymidine kinase negative system, the transformants in the A group failed to form tumors in nude mice at all. On the other hand, the clones 12-1-51 and 12-1-60 formed regressive and progressive tumors, respectively, with negative results of the colony formation in the agarose culture (Table I) .
Discussion
The experimentations, including sequential or simultaneous inoculation of cells and the treatments by ATS and ALS, as detailed in the Results, have been designed to exclude immune responses in nude mice as the causes for variable tumorigenic expressions by the sarcoma virus-transformed Indian muntjac ceils so that the tumorigenic complexity reflects only the consequence of the interaction between the sarcoma virus cells and host cells. We have found that the clonal isolates of the transformed Indian muntjac cells caused by the integration of the proviral sarcoma gene of a mouse retrovirus, 43-2XV, have four different patterns of tumorigenicity. The variable tumorigenic expressions do not correlate with the in vitro markers commonly observed in the cell transformation, such as growth behaviors, anchorage independency, or the status of virus shedding or nonproducer. The studies of two different host cells, diploid muntjac and heteroploid mouse, both transformed by the same sarcoma gene, support the conclusion (6, 7; Hatanaka et al. Manuscript in preparation; and Results). The transformed Indian muntjac cells with stable diploidy have further advantages when they are used to study the mechanism of viral oncogenesis. Chromosomal aberrations, translocations, or gene dosage effects by abnormal ploidy, are not the factors for the phenotypic differences on tumorigenicity observed in the Indian muntjac study. Thus, variable patterns on tumorigenicity from the same host cells transformed by the same virus may be derived from the variable interactions between the cell and the virus. Although it is premature to speculate, a specific chromosome(s) or a specific site(s) of the integrations of the proviral sarcoma gene may produce a specific expression of tumorigenicity. There are at least two chromosomes and four recombinant sites assigned for the integration of the sarcoma gene into the Indian muntjac gene (Hatanaka et al. Manuscript in preparation.). This hypothesis is strengthened by the use of the cloned host cells with stable diploidy, the clonal isolates of the diploid transformed cell, and the highly sarcomagenic cloned virus, 43-2XV, together with the use of nude mice providing a neutral background for immune responses.
Summary
The transformed clonal isolates of Indian muntjac diploid cells by a mouse sarcoma virus, 43-2XV, were tested for tumorigenicity in athymic nude mice. In spite of the indistinguishable transformed morphology, the tumorigenicity exhibited four different patterns: (a) no tumor formation; (b) slowly growing regressive tumor formation; (c) rapidly growing regressive tumor formation; and (d) rapidly growing progressive tumor formation. This demonstrates that the same diploid host cells transformed by the same virus reveal variable patterns of tumorigenic expression and some transformed host cells lack the tumorigenicity entirely. The findings that there are at least two chromosomes and four recombinant sites assigned for the proviral integrations of the sarcoma gene into the Indian muntjac gene (M. Hatanaka, R. Klein, R. Kominami, T. Oikawa, H. Okabe, N. Tsuchida, E. C. Connors, and A. Carrano. Transformation of Indian muntjac diploid cells by the proviral integration of sarcoma gene of a mouse retrovirus. Manuscript in preparation.) lead us to propose a hypothesis that variable expressions of tumorigenicity under the neutral background of immune responses, may arise from variable integrations of the sarcoma gene into the host chromosome.
